Nicholas A. Magnus

Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Journal of Medicinal Chemistry · 2000 · 299 citations · Full text

An Efficient Chiral Moderator Prepared from Inexpensive (+)-3-Carene:  Synthesis of the HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor DPC 963

Goss S. Kauffman, Gregory D. Harris, Roberta L. Dorow et al. · Organic Letters · 2000 · 193 citations

Bioorganic Chemistry, Molecular Biology, Chiral Moderator +19

Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine

David M. Bender, Jingqi Bao, Anne H. Dantzig et al. · Journal of Medicinal Chemistry · 2009 · 107 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +14

General Scope of 1,4-Diastereoselective Additions to a 2(3<i>H</i>)-Quinazolinone:  Practical Preparation of HIV Therapeutics

Nicholas A. Magnus, Pat N. Confalone, Louis Storace et al. · The Journal of Organic Chemistry · 2002 · 54 citations

Engineering, Hiv Therapeutics, General Scope +18

Design of Potent and Selective 2-Aminobenzimidazole-Based p38α MAP Kinase Inhibitors with Excellent in Vivo Efficacy

Alfonso de Dios, Chuan Shih, Beatriz López de Uralde et al. · Journal of Medicinal Chemistry · 2005 · 51 citations · Full text

Pharmaceutical Science, Drug Target, Compound 18 +16